THE SIGNIFICANCE OF THE DATA EXCLUSIVITY DEBATE AND ITS IMPACT ON GENERIC DRUGS
| dc.contributor.author | RAGAVAN, SRIVIDHYA | |
| dc.date.accessioned | 2025-10-27T10:03:26Z | |
| dc.date.issued | 2017 | |
| dc.description | LAW REVIEW INTERVIEW | |
| dc.identifier.citation | SRIVIDHYA RAGAVAN, THE SIGNIFICANCE OF THE DATA EXCLUSIVITY DEBATE AND ITS IMPACT ON GENERIC DRUGS., | |
| dc.identifier.issn | 2583-5297 | |
| dc.identifier.uri | http://103.191.209.183:4000/handle/123456789/311 | |
| dc.language.iso | en | |
| dc.publisher | NLUJ | |
| dc.title | THE SIGNIFICANCE OF THE DATA EXCLUSIVITY DEBATE AND ITS IMPACT ON GENERIC DRUGS | |
| dc.type | Article |
